Related Experiment Video
Updated: Apr 21, 2026

Biobank for Translational Medicine: Standard Operating Procedures for Optimal Sample Management
Published on: November 30, 2022
Public biobanks: calculation and recovery of costs
Bruno Clément1, Martin Yuille2, Kurt Zaltoukal3
1INSERM, National Biobank Infrastructure, Paris, France. INSERM, CRB-Santé and U-991, Pontchaillou Hospital, Rennes, France. bruno.clement@inserm.fr.
Abstract:
A calculation grid developed by an international expert group was tested across biobanks in six countries to evaluate costs for collections of various types of biospecimens. The assessment yielded a tool for setting specimen-access prices that were transparently related to biobank costs, and the tool was applied across three models of collaborative partnership.
Related Concept Videos
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Drug Products: Biologics, Biosimilars and Interchangeables
Biostatistics: Overview
Discrete variables are...

